Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2022 | Next generation sequencing in breast cancer

Maria Fernanda Mosele • 5 May 2022
ESMO Breast 2022
Breast Cancer

Maria Fernanda Mosele, MD, Gustave Roussy, Villejuif, France, talks on the advantages of next generation sequencing (NGS) for accessing new treatments. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.

More from Maria Fernanda Mosele

0:46
Biological behaviour of HER2-low BC is dependent on HR expression
Maria Fernanda Mosele • 5 May 2022
0:59
The significance of HER2 expression for the activity of trastuzumab deruxtecan
Maria Fernanda Mosele • 5 May 2022

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals